Embedded Files
Welcome to the Translational Research Laboratory (TRL), School of Biotechnology, KIIT University, Bhubaneswar.
Welcome to the Translational Research Laboratory (TRL), School of Biotechnology, KIIT University, Bhubaneswar.
Our research group at KIIT is dedicated to unraveling the intricacies of the Tumor microenvironment.
We are particularly interested in how various players within the TME regulates tumor events and contributes to therapy escape.
Understanding the complex cellular networks and identifying core regulatory transcription factors that regulates tumor progression and metastasis by using CRISPR technology in various cancers is central to our research.
By using our expertise, we will establish breast, prostate, skin, gall bladder and head and neck oral cancer specific Patient Derived Xenograft (PDX) models, primary cultures and cell lines from patients and PDX models and identify potential therapeutic targets and therapeutically relevant biomarkers from cell lines, PDX and patients’ specimens using genomics and proteomics approaches for the effective targeting of cancer cells and screening of new drugs, repurposing of drugs using PDX models.
Our long-term objective is to translate our fundamental research findings into clinical applications, bridging the gap between basic science and clinical practice.
TRL aims to Translate the science into Society........
Latest Updates......
More details KIIT R & D Page
TRL is happy to share recent publication in Molecular Cancer (IF-37.3).
molecular-cancer.biomedcentral.com/articles/10.1186/s12943-024-01990-4
TRL is happy to share recent publication in NANOMATERIALS (IF-4.4).
https://www.mdpi.com/2079-4991/14/15/1294
TRL is happy to share recent publication in Biomedicines (IF-3.9) and Cancers (IF-4.5).
https://www.mdpi.com/2227-9059/12/7/1527
https://www.mdpi.com/2072-6694/17/2/234
KIIT Deemed to be University congratulates Prof. Gopal C. Kundu, Director R&D, KIIT-DU, Professor of Biotechnology, KIIT School of Biotechnology and Professor of Medicine and Molecular Research, Kalinga Institute of Medical Sciences, for being awarded the J. C. Bose National Fellowship for four years (2023-2027). The J.C. Bose fellowship is awarded to active scientists in recognition for their outstanding performance in research at the National and International levels. This fellowship is scientist-specific and very selective.
ANOTHER PATENT GRANTED IN COLLABORATION WITH IIT BOMBAY and NCCS, Pune.
KIIT R & D Director Prof. Gopal Chandra Kundu has been elected as a fellow of the Indian National Science Academy (INSA) and Royal Society of Chemistry (FRSC) in 2023.
Based on Oncogene, 2021 Paper published from KIIT University and National Center for Cell Science (NCCS), Pune on studying Tumor-stroma interaction in breast cancer, Oncotarget has recently published an Editorial and Video interview of Prof. Gopal C Kundu, Director-R&D, KIIT on targeting Cancer Associated Fibroblasts (CAF) in association with Cancer Cells as targeted therapy for the management of breast cancer (https://youtu.be/5WYoYwXIKUc).
KIIT R & D Director Prof. Gopal Chandra Kundu has felicitated by Prof. (Dr.) Achyuta Samanta, Founder Sir and Prof. Sasmita Samanta, Vice Chancellor, KIIT-DU for undertaking highest number of govt. funded projects throughout KIIT-DU in 2023.
KIIT R & D Director Prof. Gopal Chandra Kundu and his team celebrates ART of GIVING :"I AM AOG PACTITIONER"
Page updated
Google Sites
Report abuse